Skip to main content
Premium Trial:

Request an Annual Quote

Multispan and Promega to Co-Develop Cell-Based GPCR Screening Tools

NEW YORK (GenomeWeb News) - Multispan and Promega said yesterday that they will co-develop assay tools for G-protein coupled receptor screening using Multispan’s GPCR cell lines and Promega’s bioluminescent technology.
The companies said that the initial tools to be developed under the agreement will use Promega’s cAMP-Glo Assay technology for signal quantification. The partners said they will develop additional tools for “cell-based assay detection,” but did not provide further details.
John Watson, marketing director for pharma and biotech at Promega, said that the protocols developed under the partnership should reduce assay-development times “from months to days.”
Financial details of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.